Our top pick for
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Stride Inc is an education & training services business with stocks listed in the US. Stride shares (LRN) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was US$35.24 – an increase of 1.97% over the previous week. Here's how to invest if you're based in Australia.
|52-week range||US$20.39 - US$37.6|
|50-day moving average||US$34.7979|
|200-day moving average||US$31.6086|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||US$1.71|
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|1 week (2021-10-14)||1.97%|
|1 month (2021-09-21)||4.88%|
|3 months (2021-07-21)||9.51%|
|6 months (2021-04-21)||17.47%|
|1 year (2020-10-21)||23.78%|
|2 years (2019-10-21)||39.01%|
|3 years (2018-10-19)||105.84%|
|5 years (2016-10-21)||145.40%|
Valuing Stride stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Stride's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Stride's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 20x. In other words, Stride shares trade at around 20x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Stride's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.9797. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Stride's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Stride's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$160.5 million (£0.0 million).
The EBITDA is a measure of a Stride's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||US$1.5 billion|
|Operating margin TTM||7.41%|
|Gross profit TTM||US$530.2 million|
|Return on assets TTM||5.37%|
|Return on equity TTM||9.66%|
|Market capitalisation||US$1.4 billion|
TTM: trailing 12 months
There are currently 2.7 million Stride shares held short by investors – that's known as Stride's "short interest". This figure is 3.9% down from 2.9 million last month.
There are a few different ways that this level of interest in shorting Stride shares can be evaluated.
Stride's "short interest ratio" (SIR) is the quantity of Stride shares currently shorted divided by the average quantity of Stride shares traded daily (recently around 467518.39863714). Stride's SIR currently stands at 5.87. In other words for every 100,000 Stride shares traded daily on the market, roughly 5870 shares are currently held short.
However Stride's short interest can also be evaluated against the total number of Stride shares, or, against the total number of tradable Stride shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Stride's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 Stride shares in existence, roughly 70 shares are currently held short) or 0.073% of the tradable shares (for every 100,000 tradable Stride shares, roughly 73 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Stride.
Find out more about how you can short Stride stock.
We're not expecting Stride to pay a dividend over the next 12 months.
Over the last 12 months, Stride's shares have ranged in value from as little as US$20.39 up to US$37.6. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Stride's is 0.6069. This would suggest that Stride's shares are less volatile than average (for this exchange).
Stride, Inc., a technology-based education company, provides proprietary and third-party online curriculum, software systems, and educational services to facilitate individualized learning for students primarily in kindergarten through 12th grade (K-12) in the United States and internationally. Its technology-based products and services enable clients to attract, enroll, educate, track progress, and support students. The company offers integrated package of systems, services, products, and professional expertise to support a virtual or blended public school; and products and services for the general education market focused on subjects, including math, English, science, and history for kindergarten through twelfth grade students. It also provides career learning products and services that are focused on developing skills to enter in industries, including information technology, health care, and business; and focused post-secondary career learning programs, which include skills training for the data science, software engineering, healthcare, and medical fields to adult learners under Galvanize, Tech Elevator, and MedCerts brand names, as well as provides staffing and talent development services to employers. Stride, Inc. serves consumers, employers, and government agencies. The company was formerly known as K12 Inc. and changed its name to Stride, Inc. in December 2020. Stride, Inc. was founded in 2000 and is headquartered in Herndon, Virginia.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Shares in the wealth management giant have been largely stable in the last 6 months.
Everything we know about the Judo Capital Holdings IPO, plus information on how to buy in.
Everything we know about the Allaggio Group IPO, plus information on how to buy in.
Everything we know about the Larvotto Resources IPO, plus information on how to buy in.
Everything we know about the Vulcan Steel IPO, plus information on how to buy in.
Everything we know about the Artrya IPO, plus information on how to buy in.
Everything we know about the 8 Au IPO, plus information on how to buy in.
Everything we know about the Radiopharm Theranostics IPO, plus information on how to buy in.
The online retailer’s shares have lost more than half their value in the last 12 months.
finder.com.au is one of Australia's leading comparison websites. We compare from a wide set of banks, insurers and product issuers. We value our editorial independence and follow editorial guidelines.
finder.com.au has access to track details from the product issuers listed on our sites. Although we provide information on the products offered by a wide range of issuers, we don't cover every available product or service.
Please note that the information published on our site should not be construed as personal advice and does not consider your personal needs and circumstances. While our site will provide you with factual information and general advice to help you make better decisions, it isn't a substitute for professional advice. You should consider whether the products or services featured on our site are appropriate for your needs. If you're unsure about anything, seek professional advice before you apply for any product or commit to any plan.
Products marked as 'Promoted' or 'Advertisement' are prominently displayed either as a result of a commercial advertising arrangement or to highlight a particular product, provider or feature. Finder may receive remuneration from the Provider if you click on the related link, purchase or enquire about the product. Finder's decision to show a 'promoted' product is neither a recommendation that the product is appropriate for you nor an indication that the product is the best in its category. We encourage you to use the tools and information we provide to compare your options.
Where our site links to particular products or displays 'Go to site' buttons, we may receive a commission, referral fee or payment when you click on those buttons or apply for a product. You can learn more about how we make money here.
When products are grouped in a table or list, the order in which they are initially sorted may be influenced by a range of factors including price, fees and discounts; commercial partnerships; product features; and brand popularity. We provide tools so you can sort and filter these lists to highlight features that matter to you.
We try to take an open and transparent approach and provide a broad-based comparison service. However, you should be aware that while we are an independently owned service, our comparison service does not include all providers or all products available in the market.
Some product issuers may provide products or offer services through multiple brands, associated companies or different labelling arrangements. This can make it difficult for consumers to compare alternatives or identify the companies behind the products. However, we aim to provide information to enable consumers to understand these issues.
Providing or obtaining an estimated insurance quote through us does not guarantee you can get the insurance. Acceptance by insurance companies is based on things like occupation, health and lifestyle. By providing you with the ability to apply for a credit card or loan, we are not guaranteeing that your application will be approved. Your application for credit products is subject to the Provider's terms and conditions as well as their application and lending criteria.